Idesign RS
Device
PDI 05050474651432
General payments
$117,084
Research payments
$1,320,768
Through program year 2025, $117,084 in general payments and $1,320,768 in research payments were reported against Idesign RS.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $239 | 4 |
| 2025 | Research | $15,850 | 9 |
| 2024 | General | $8,815 | 82 |
| 2024 | Research | $147,375 | 25 |
| 2023 | General | $19,957 | 24 |
| 2023 | Research | $529,500 | 62 |
| 2022 | General | $19,194 | 75 |
| 2022 | Research | $378,639 | 43 |
| 2021 | General | $68,879 | 61 |
| 2021 | Research | $249,404 | 38 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
246 general · 177 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.